PRKCB, protein kinase C beta, 5579

N. diseases: 317; N. variants: 18
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.250 Biomarker phenotype BEFREE TRPM8 channel, PKC and NF-κB are potential targets for cold hyperalgesia treatment in neuropathic pain patients. 31114308 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.250 Biomarker phenotype BEFREE PERSPECTIVE: This study demonstrates that the activation of Cavα2δ1 and the downstream PKC-TRPA1/GJ signaling pathway contributes greatly to trigeminal nerve injury-induced secondary mechanical and cold hyperalgesia. 31494272 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.250 Biomarker phenotype BEFREE Furthermore, intrathecal injection of PKC but not PKA blocker prevented the development of chronic pain and PKC agonist was sufficient to induce prolonged hyperalgesia response after acid injection. 29351171 2018
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.250 Biomarker phenotype BEFREE In the present study, we examined the theory that PKC activation lead to nuclear translocation and cytosolic HMGB1 secretion, which subsequently induces spinal neuro inflammatory responses (cytokine release) causing hyperalgesia. 29428215 2018
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.250 Biomarker phenotype BEFREE Enhancement of spinal dorsal horn neuron NMDA receptor phosphorylation as the mechanism of remifentanil induced hyperalgesia: Roles of PKC and CaMKII. 28714352 2018
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.250 Biomarker phenotype RGD Agents that act by different mechanisms modulate the activity of protein kinase CbetaII isozyme in the rat spinal cord during peripheral inflammation. 16360284 2006